Pancreas Transfection Kit

Modes of administration

Systemic intravenous (i.v.) injectionDirect intratumoral (i.t.) injectionIntraperitoneal (i.p.) injection

Description

The pancreas is the second largest gland in the human body after the liver and can secrete pancreatic juice and insulin Pancreas juice contains arthritis A variety of digestive enzymes play an important role in the digestion of food. Therefore, when it is abnormal, it often causes various clinical diseases, such as acute/chronic pancreatitis, pancreatic cancer and insulinoma, etc. These pancreatic diseases seriously threaten human health. To help researchers explore the mechanism of these diseases and find appropriate therapeutic drugs. CD BioSciences has developed a in vivo pancreatic-targeted delivery system that targets pancreatic cells. This system can localize the delivery molecule to the pancreatic lesion site, reduce the dosage and administration frequency of the research molecule, and improve the curative effect. Through the pancreas-targeted delivery system, siRNA, DNA and other active molecules are precisely delivered to pancreatic cells, enhancing the solubility of insoluble drugs, protecting drugs from degradation, producing slow and controlled release, reversing multidrug resistance, and changing pharmacokinetics biological processes, changes in biodistribution in vivo and other characteristics. To help advance in vivo experimental research, CD BioSciences has developed the Pancreas In Vivo Kit for related research.

CD BioSciences manufactures and supplies the Pancreas In Vivo Kit for in vivo studies. Contact us to find out how the Pancreas In Vivo Kit can help your work.